CHICAGO — Exelon Corporation (NYSE: EXC) announced today that it has successfully remarketed its 2.5 percent Junior Subordinated Notes due 2024 (the “Original Notes”), which were originally issued on June 17, 2014, as a component of Exelon’s Equity Units.
The Original Notes are being remarketed into $1,150,000,000 aggregate principal amount of 3.497 percent Junior Subordinated Notes due 2022 (the “Remarketed Notes”). Effective April 3, 2017, the Remarketed Notes will bear interest at 3.497 percent per year and will mature on June 1, 2022. The remarketing is expected to close on April 3, 2017, subject to customary closing conditions.
Exelon conducted the remarketing on behalf of holders of the Equity Units and will not directly receive any proceeds from the issuance and sale of the Remarketed Notes. The proceeds from the issuance and sale of the Remarketed Notes will be used to purchase a portfolio of treasury securities maturing on or about May 31, 2017. Exelon expects that a portion of the funds generated upon maturity of the portfolio will be used on June 1, 2017 to settle the purchase contracts it entered into as a part of the Equity Units.
The remarketing is being made pursuant to an effective shelf registration statement of Exelon that has been filed with the U.S. Securities and Exchange Commission (SEC). This press release does not constitute an offer to sell or a solicitation of an offer to buy the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities law of any such jurisdiction. The offering of notes in connection with the remarketing may only be made by means of a prospectus and related prospectus supplement, copies of which may be obtained at no cost by visiting EDGAR on the SEC's website at www.sec.gov or by contacting the following companies by mail, phone or email:
Citigroup Global Markets Inc.
c/o Broadridge Financial Solutions
1155 Long Island Avenue, Edgewood, New York 11717
Phone: (800) 831-9146
Goldman, Sachs & Co.,
200 West Street, New York, New York 10282
Phone: (866) 471-2526
Merrill Lynch, Pierce, Fenner & Smith Incorporated,
NC1-004-03-43, 200 North College Street, Third Floor, Charlotte, North Carolina
Phone: (800) 294-1322
Cautionary Statements Regarding Forward-Looking Information
This press release contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to risks and uncertainties. The factors that could cause actual results to differ materially from the forward-looking statements made by Exelon include those factors discussed herein and in the prospectus supplements and base prospectus filed in connection with the Remarketed Notes offering, as well as the items discussed in (1) Exelon’s 2016 Annual Report on Form 10-K in (a) ITEM 1A. Risk Factors, (b) ITEM 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations and (c) ITEM 8. Financial Statements and Supplementary Data: Note 24: Commitments and Contingencies (All Registrants) to the consolidated financial statements; and (2) other factors discussed in filings with the SEC by Exelon. Readers are cautioned not to place undue reliance on these forward-looking statements, which apply only as of the date of this press release. None of the Registrants undertakes any obligation to publicly release any revision to its forward-looking statements to reflect events or circumstances after the date of this press release.